Skip to main content

Clinical Safety of a PBM Program

0
Pipeline Programs
4
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Fresenius Kabi
Fresenius KabiGermany - Bad Homburg
1 program
The German Patient Blood Management NetworkN/A
CSL Behring
CSL BehringIL - Bradley
1 program
The German Patient Blood Management NetworkN/A
B. Braun
B. BraunGermany - Melsungen
1 program
The German Patient Blood Management NetworkN/A
CSL Seqirus
CSL SeqirusUK - Maidenhead
1 program
The German Patient Blood Management NetworkN/A1 trial
Active Trials
NCT02147795Unknown1,000,000Est. Dec 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
CSL SeqirusThe German Patient Blood Management Network

Clinical Trials (1)

Total enrollment: 1,000,000 patients across 1 trials

NCT02147795CSL SeqirusThe German Patient Blood Management Network

The German Patient Blood Management Network

Start: Jan 2012Est. completion: Dec 20251,000,000 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Safety of a PBM Program | Pipeline & Competitive Landscape | Formulate